AR111017A1 - HEMISULFATE SALT OF A NUCLEOTID COMPOUND FOR THE TREATMENT OF HEPATITIS C VIRUS - Google Patents

HEMISULFATE SALT OF A NUCLEOTID COMPOUND FOR THE TREATMENT OF HEPATITIS C VIRUS

Info

Publication number
AR111017A1
AR111017A1 ARP180100244A ARP180100244A AR111017A1 AR 111017 A1 AR111017 A1 AR 111017A1 AR P180100244 A ARP180100244 A AR P180100244A AR P180100244 A ARP180100244 A AR P180100244A AR 111017 A1 AR111017 A1 AR 111017A1
Authority
AR
Argentina
Prior art keywords
hepatitis
virus
nucleotid
compound
treatment
Prior art date
Application number
ARP180100244A
Other languages
Spanish (es)
Inventor
Jean Sommadossi
- Moussa Adel Pierre
Original Assignee
Atea Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atea Pharmaceuticals Inc filed Critical Atea Pharmaceuticals Inc
Publication of AR111017A1 publication Critical patent/AR111017A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una sal hemisulfato con la estructura de fórmula (1) para tratar un huésped infectado con el virus de la hepatitis C así como composiciones y formas de dosificación del mismo, que incluyen formas de dosificación sólidas.A hemisulfate salt with the structure of formula (1) to treat a host infected with the hepatitis C virus as well as compositions and dosage forms thereof, which include solid dosage forms.

ARP180100244A 2017-02-01 2018-02-01 HEMISULFATE SALT OF A NUCLEOTID COMPOUND FOR THE TREATMENT OF HEPATITIS C VIRUS AR111017A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762453437P 2017-02-01 2017-02-01

Publications (1)

Publication Number Publication Date
AR111017A1 true AR111017A1 (en) 2019-05-29

Family

ID=66669213

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180100244A AR111017A1 (en) 2017-02-01 2018-02-01 HEMISULFATE SALT OF A NUCLEOTID COMPOUND FOR THE TREATMENT OF HEPATITIS C VIRUS

Country Status (1)

Country Link
AR (1) AR111017A1 (en)

Similar Documents

Publication Publication Date Title
CO2019009215A2 (en) Hemi-sulfate nucleotide salt for the treatment of hepatitis C virus
DOP2019000201A (en) HIV INHIBITING COMPOUNDS
CO2019001379A2 (en) Therapeutic compounds useful for the prophylactic or therapeutic treatment of a hiv virus infection.
NI201700020A (en) AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS
CR20160564A (en) CYCLIC DINUCLEOTIDES AS STING MODULATORS
CL2017000379A1 (en) Pyrrolopyrimidine compounds used as toll receptor agonists. 7 (tlr7)
CO2019004034A2 (en) Pyridine compound
BR112016023558A2 (en) compounds useful as immunomodulators
CL2016000493A1 (en) Hcv polymerase inhibitors
CL2015003615A1 (en) Substituted nucleosides, nucleotides and analogs thereof.
DOP2016000085A (en) AMINO-HETEROARIL-BENZAMIDAS AS CINASA INHIBITORS
GT201500020A (en) SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
UY35362A (en) THERAPEUTIC COMPOUNDS
CL2020000487A1 (en) Antiviral agents against hepatitis b.
UY36340A (en) DERIVATIVES OF MONO- OR DISPOSED INDOLES AS INHIBITORS OF THE REPLICATION OF THE DENGUE VIRUS
CL2014003634A1 (en) Hepatitis C virus inhibitors
EA201790266A1 (en) INDOLS FOR USE IN INFECTIONS CAUSED BY THE FLU VIRUS
AR099632A1 (en) TREATMENT OF A VIRAL INFECTION OF HEPATITIS C, THAT USES A COMBINATION OF COMPOUNDS
EA201790571A1 (en) PYRROPHYRIMIDINES FOR APPLICATION IN INFECTION CAUSED BY THE FLU VIRUS
CL2016002835A1 (en) "Compounds derived from pladienolide with a pyridinic moiety; pharmaceutical composition comprising them; and its use in cancer treatment. ” pct
PH12017501598A1 (en) �-D-2`-DEOXY-2`a-FLUORO-2`-�-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
EA201790700A1 (en) MONO OR DESIGNED INDOLS AS AN INHIBITORS REPLICATION OF DENG VIRUSES
DOP2016000336A (en) ISOINDOLIN DERIVATIVES FOR USE IN THE TREATMENT OF A VIRAL INFECTION
GT201500247A (en) IMIDAZOPIRIDAZINAS REPLACED
CL2016002879A1 (en) Pharmaceutical compositions for treating infectious diseases